Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Glucagon (GlucaGen / Baqsimi) Peptide
29-amino-acid peptide hormone for severe hypoglycemia.
What is Glucagon (GlucaGen / Baqsimi)?
Glucagon (GlucaGen / Baqsimi) is a counter-regulatory hormone · endocrine peptide studied for severe hypoglycemia (t1d/t2d) and beta-blocker overdose. Below is an educational overview of Glucagon (GlucaGen / Baqsimi) peptide benefits, mechanism, common research protocols, dosage references, and known side effects.
Plain-Language Label Highlights
Brand names: GlucaGen, Baqsimi (nasal), Gvoke (auto-injector)
Severe low blood sugar in people with diabetes; also used to relax GI smooth muscle for imaging.
An emergency treatment (injection or nasal powder) that quickly raises blood sugar when someone with diabetes is unable to eat or drink.
- •Nausea/vomiting after recovery
- •Headache
- •Nasal irritation (Baqsimi)
- •Severe allergic reactions
- •Necrolytic migratory erythema with prolonged infusion
- •Caution in pheochromocytoma, insulinoma, glucagonoma
- •Pheochromocytoma
- •Insulinoma
- •Known glucagonoma
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Glucagon (GlucaGen / Baqsimi) Mechanism of Action
Pancreatic alpha-cell peptide hormone that activates hepatic glucagon receptors, stimulating glycogenolysis and gluconeogenesis to raise blood glucose; also relaxes GI smooth muscle (used in radiology).
Glucagon (GlucaGen / Baqsimi) Research Areas & Benefits
Glucagon (GlucaGen / Baqsimi) Dosage & Common Research Protocols
1 mg IM/SC; pediatric weight-based.
3 mg single intranasal dose.
Protocols summarized for educational reference from published research. Not dosing guidance.
Glucagon (GlucaGen / Baqsimi) Studies & Cited Research
Nasal glucagon (Baqsimi) trials
Non-inferior glucose response vs IM glucagon, easier administration.
Why we trust this source: Published in a peer-reviewed scientific journal with editorial and reviewer oversight.
Citations are linked to PubMed, Google Scholar, and Crossref searches so you can verify the source independently. All references are reviewed during our editorial passes (last reviewed June 1, 2026).
Glucagon (GlucaGen / Baqsimi) Side Effects & Safety Considerations
- •FDA-approved.
- •Nausea/vomiting common after recovery.
Common questions about Glucagon (GlucaGen / Baqsimi)
More Hormonal peptides · See all 14
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.